印度Advinus  
Advinus制药位于印度班加罗尔，该公司拥有一个化学工艺、药代动力学、临床药理学、安全评估、分析研发、生物分析、既定配方开发的集成化服务平台。由塔塔集团建立

Advinus Therapeutics is a research-based Pharmaceutical Company founded by leading global pharmaceutical executives and promoted by the TATA Group. The company is the first of its kind in India to offer end-to-end development services to the global Pharma, Agro and Biotech industries and at the same time creating long-term value through internal and collaborative innovative Drug Discovery.

Advinus has three operational sites. Advinus Drug Discovery, which is located in a state of the art facility in Pune (near Mumbai) is developing its own drug candidates with the objective of out-licensing them at preclinical or clinical stages. The therapeutic areas of focus of these programs are in Metabolic Diseases and Inflammatory Diseases.

Advinus is also working on the discovery of novel therapies for neglected diseases such as Leishmaniasis and Malaria. The aim of this program is to discover and develop new drugs for neglected diseases with speed, efficiency and cost effectiveness. India is ideally suited for this activity due to public health issues of the country, availability of talent and cost effectiveness. Advinus is committed to addressing these global public health issues.

Advinus’ Pharmaceutical development Bangalore operation, is located on a 8 acre campus with 220,000 sq. ft of modern facilities. This business offers an end-to-end pre-clinical to early clinical development platform for pharmaceutical product development.

The agro chemical development center is located about 3 kilometers away from the pharmaceutical development center.

Spiraling R&D costs, flat productivity and an ever increasing pressure on time-to-market have become issues that pharmaceutical organizations, the world over, are grappling with. Advinus’ CRO Bangalore operations provide clients with cost-efficient services in the areas of Process Development, Drug Metabolism and Pharmacokinetics, Clinical Pharmacology, Safety Assessment and Analytical R&D. The Bangalore center is also one of the most accredited R&D centers of India with certification from AAALAC International and from the German, Dutch and Indian authorities for GLP compliance.

In its management and senior leadership the team has over 15-20 years of drug discovery and drug development experience in U.S. large Pharmaceutical companies, with experiences handling dozens of IND and NDA filings.
VISION

To emerge as the leading and most admired life - sciences R&D company from India creating value for its customers and stakeholders

MISSION

To be the leading discovery organization in India as judged by the quality of its leadership and people, discovery programs, partnerships, productivity through INDs and successful out-licensing
To be the first choice pharmaceutical and agro-chemical development service provider in India, by offering innovative solutions and comprehensive services in the development value chain
To leverage the India advantage whilst maintaining global quality and speed
To address our corporate social responsibility towards needs of the developing nations of the world, through our focused "Neglected Diseases Program"